Trials that use: Covariate adjustment
5,848 results
- Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin’s Lymphoma: Complete Statistical AnalysisIndependent statistical analysis of Rituximab, Cyclophosphamide, and Pegfilgrastim in Treating Patients With Leukemia or Non-Hodgkin's Lymphoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RLICCIndependent statistical analysis of Effect of Number of Remote Limb Ischemic Conditioning Cycles on Learning Enhancement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- RLSIndependent statistical analysis of Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Robotic and Conventional Hand Therapy After Stroke: Complete Statistical AnalysisIndependent statistical analysis of Robotic and Conventional Hand Therapy After Stroke: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03020576).
- Robotic Arm Assisted Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Robotic Arm Assisted Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02058069).
- Robotic Gait Rehabilitation in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Robotic Gait Rehabilitation in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05218187).
- Robotic Pedaling Therapy for Targeted Neural Plasticity: Complete Statistical AnalysisIndependent statistical analysis of Robotic Pedaling Therapy for Targeted Neural Plasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03300258).
- Robotic Walking Device to Improve Mobility in Parkinson’s Disease: Complete Statistical AnalysisIndependent statistical analysis of Robotic Walking Device to Improve Mobility in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03751371).
- ROCKETIndependent statistical analysis of A Phase 2 Randomized, Open-Label Study of RRx-001 vs Regorafenib in Subjects With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ROCKET AFIndependent statistical analysis of ROCKET AF, the randomized phase 3 trial of rivaroxaban versus warfarin for prevention of stroke and non-CNS systemic embolism in patients with non-valvular atrial fibrillation.
- Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS): Complete Statistical AnalysisIndependent statistical analysis of Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS): primary endpoint results, effect estimate with confidence…
- Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01664624).
- Role of Magnesium Supplementation in the Treatment of Depression: Complete Statistical AnalysisIndependent statistical analysis of Role of Magnesium Supplementation in the Treatment of Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02466087).
- Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA): Complete Statistical AnalysisIndependent statistical analysis of Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01198509).
- Role of Pancreatic Triglyceride Content in Beta-cell Function: Complete Statistical AnalysisIndependent statistical analysis of Role of Pancreatic Triglyceride Content in Beta-cell Function: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00602953).
- Role of Proinflammatory Signaling in Alcohol Craving: Complete Statistical AnalysisIndependent statistical analysis of Role of Proinflammatory Signaling in Alcohol Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01631630).
- Role of Skeletal Muscle Nitric Oxide Production in Age-related Fatigue and Fatigability: Complete Statistical AnalysisIndependent statistical analysis of Role of Skeletal Muscle Nitric Oxide Production in Age-related Fatigue and Fatigability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Role of Soy Supplementation in Prostate Cancer Development: Complete Statistical AnalysisIndependent statistical analysis of Role of Soy Supplementation in Prostate Cancer Development: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00255125).
- Role of the Supraspinal Opioidergic Circuit in Prefrontal TMS-Induced Analgesia: Complete Statistical AnalysisIndependent statistical analysis of Role of the Supraspinal Opioidergic Circuit in Prefrontal TMS-Induced Analgesia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01643798).
- Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303: Complete Statistical AnalysisIndependent statistical analysis of Roll-over Study to Assess Safety of Lixivaptan in Participants With ADPKD Who Completed Study PA-ADPKD-303: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor: Complete Statistical AnalysisIndependent statistical analysis of Rollover Study to Evaluate the Safety and Efficacy of Long-term Treatment With Lumacaftor in Combination With Ivacaftor: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- ROMEO (Rosuvastatin in Metabolic syndrOme): Complete Statistical AnalysisIndependent statistical analysis of ROMEO (Rosuvastatin in Metabolic syndrOme): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00395486).
- Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS): Complete Statistical AnalysisIndependent statistical analysis of Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ROPIndependent statistical analysis of Efficient Study of ACULAR in Inhibiting Proliferative Retinopathy in Prematurity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00634972).
- Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery: Complete Statistical AnalysisIndependent statistical analysis of Ropivacaine Block Alone or With Perineural or Systemic Dexamethasone for Pain in Shoulder Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ROSEIndependent statistical analysis of A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ROUTE-T1DIndependent statistical analysis of Research on Optimizing the Use of Technology With Education: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05564481).
- ROXI-VTE IIIndependent statistical analysis of A Trial to Learn How Well REGN7508 Works for Preventing Blood Clots After a Knee Replacement in Adult Participants: primary endpoint results, effect estimate with confidence interval, sample-size…
- RPCWIndependent statistical analysis of Prevention of Alcohol-related Sexual Revictimization in College: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05257603).
- RRRIndependent statistical analysis of Study of the Efficacy and Tolerability of Intravitreal Injections of Ranibizumab Compared to Intravitreal Injections of Ranibizumab Combined With Targeted Retinal Photocoagulation to Treat Radiation Retinopathy.: primary endpoint…
- RSLV-132Independent statistical analysis of A Study of RSLV-132 in Subjects With Primary Sjogren's Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03247686).
- RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery: Complete Statistical AnalysisIndependent statistical analysis of RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- RTGIndependent statistical analysis of Room to Grow Evaluation for Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04226053).
- RTOG 0617Independent statistical analysis of RTOG 0617, evaluating radiation therapy dose and cetuximab with chemotherapy in newly diagnosed unresectable stage III non-small cell lung cancer, with emphasis on survival, competing risks, safety, and…
- RUBATOIndependent statistical analysis of Clinical Study Assessing the Efficacy and Safety of Macitentan in Fontan-palliated Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Rural NDPPIndependent statistical analysis of The National Diabetes Prevention Program in Rural Communities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05387434).
- Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RVD LiteIndependent statistical analysis of Lenalidomide/Bortezomib/Dexamethasone for Multiple Myeloma (MM): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01782963).
- RxPONDERIndependent statistical analysis of the randomized phase 3 RxPONDER trial, including its invasive disease-free survival endpoint, Cox proportional-hazards analyses, menopausal-status interaction, post-hoc distant relapse-free survival results, safety, and statistical interpretation.
- S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C: Complete Statistical AnalysisIndependent statistical analysis of S-Adenosyl Methionine (SAMe) to Treat Patients With Chronic Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00475176).
- S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma: Complete Statistical AnalysisIndependent statistical analysis of S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma: primary endpoint results, effect estimate with confidence…
- S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.: Complete Statistical AnalysisIndependent statistical analysis of S0307 Phase III Trial of Bisphosphonates as Adjuvant Therapy for Primary Breast Cancer.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction: Complete Statistical AnalysisIndependent statistical analysis of S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction: primary endpoint results, effect estimate with confidence…
- S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer: Complete Statistical AnalysisIndependent statistical analysis of S0819: Carboplatin and Paclitaxel With or Without Bevacizumab and/or Cetuximab in Treating Patients With Stage IV or Recurrent Non-Small Cell Lung Cancer: primary endpoint results, effect estimate with…
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer: Complete Statistical AnalysisIndependent statistical analysis of S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SACARIndependent statistical analysis of Strategies for Aggressive Central Afterload Reduction in Patients With Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- SACRPIndependent statistical analysis of Study of Anaesthesia Costs and Recovery Profiles: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02920749).
- SAD-PDIndependent statistical analysis of Study of Antidepressants in Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00086190).
- SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of SAD, MAD and Food Effect Evaluation of Safety, Tolerability, and PK of AQ280 in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…